TSC22D3 and melanoma: These findings are supported by the data obtained using human HBL H2B-GFP melanoma cells, which revealed that GILZ KD significantly delayed the capacity of these cells to initiate tumours in SCID mice but increased their tumourigenic potential (Fig. 5d).